Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05113238
Other study ID # 003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2021
Est. completion date December 30, 2021

Study information

Verified date September 2022
Source Royal Fertility Center, Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be conducted to compare two different Assisted Gamete treatment (AGT) with oocyte-sibling-split design control group : AGT- initial protocol for activating oocytes by culturing oocytes in calcium ionophore after injection for two rounds of 10 minutes at 37 C, 30 minutes after injection. sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after injection for 10 minutes


Description:

investigators performed ICSI then with one of two activation protocols added : AGT-initial or AGT-revised For the AGT initial protocol, Oocytes will be injected then will be incubated in 10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes after ICSI injection, and then will be rinsed and transferred into culture medium. For the AGT-revised protocol, ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate polyvinylpyrrolidone drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and will be injected into the oocyte with the spermatozoa. Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37 C, and then will be washed and placed in culture medium.


Recruitment information / eligibility

Status Completed
Enrollment 222
Est. completion date December 30, 2021
Est. primary completion date December 25, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - couples presented with an extremely poor fertilization (<10%) - couples with previous complete fertilization failure after undergoing ICSI cycles - At least 4 MII oocytes - Severe oligoasthinozoospermia - Teratozoospermia - testicular aspirated sperm Exclusion Criteria: - age >40 years - BMI >34 - aspirated oocytes < 4 - Normozoospermia - subfertile patients

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Assisted gamete activation
compare two different assisted gamete activation protocols to improve ICSI outcome

Locations

Country Name City State
Egypt Royal Fertility Center Mansoura Daqahlya

Sponsors (2)

Lead Sponsor Collaborator
Royal Fertility Center, Egypt Hawaa Fertility Center

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of top quality day 3 embryos number of top quality embryos 3 days after ICSI procedure day
Primary Number of Top quality day 4 embryos number of top quality embryos 4 days after ICSI procedure
Primary Number of Top quality day 5 embryos number of top quality embryos 5 days after ICSI procedure
Secondary chemical pregnancy rate the number of positive pregnancy cases from overall cases 15 days after embryo transfer procedure day
See also
  Status Clinical Trial Phase
Completed NCT05113225 - Sperm Micro-swim up Technique; Process and Select in the Same Dish: a Sibling-oocyte-split Design N/A
Completed NCT03881072 - Evaluating the Endometrial Receptivity of FET Patient by Ultrasounicelastography N/A
Recruiting NCT04897269 - Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day Phase 3
Completed NCT02190422 - Effect of Assisted Reproductive Technology on Cardiac Development in Childhood Assessed by Echocardiography N/A
Recruiting NCT06238570 - Validation of Donor Oocytes Semi-automated Vitrification N/A
Recruiting NCT03756857 - Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization? N/A
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Completed NCT02171884 - Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans
Not yet recruiting NCT05164029 - The Clinical Cohort Study of Reproductive Health
Active, not recruiting NCT05404464 - Construction of CITIC Xiangya Assisted Reproduction Data Repository
Active, not recruiting NCT02109900 - Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome N/A
Active, not recruiting NCT04741295 - Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome N/A
Not yet recruiting NCT05738382 - Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures Phase 2
Withdrawn NCT02520869 - Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Assisted Reproduction Treatment Phase 2/Phase 3